Overall, CXCL1/2/3/4/5/8/9/10/11/13/14/16 are highly expressed in CRC patients, thereby serving as an oncogene in CRC in addition to their association with prognosis. This evidence concerns the gene CXCL1 and colorectal carcinoma.